Skip to main content
Main navigation
  • Find Care
    • Find Care
    • Convenient Care
    • Emergency Care
    • Primary Care
    • Urgent Care
    • Virtual Care
  • Specialties & Services
    • Specialties & Services
    • Cancer
    • Gastrointestinal and Digestive Care
    • Heart & Vascular
    • Neurosciences
    • Obstetrics & Gynecology
    • Orthopedics
    • Primary Care
    • Therapy & Rehabilitation
    • Transplant
  • Locations
    • Locations
    • Hospitals
    • Hospice & Palliative Care
    • Labs & Imaging
    • Pharmacies
    • Physician Practices
    • Rehabilitation Centers
    • Same Day Care
    • Senior Living
    • Surgery
  • Patients & Visitors
    • Patients & Visitors
    • Advance Directives
    • Billing
    • Classes & Events
    • Financial Assistance
    • Insurance
    • Medical Records
    • Online Pre-Registration
    • Patient & Family Advisory Council Application
    • Patient Experience Survey
    • Patient Privacy
    • Patient Rights and Responsibilities
    • Preparing for Your Visit
    • Recognize a Saint Luke's Employee
    • Safety & Security During Your Hospital Stay
    • Spiritual Wellness
  • mySaintLuke's
  • About
  • Careers
  • Contact Us
  • Giving
  • Pay a Bill
  • News
  • BJC.org
Find a Provider
  • Saint Luke's Research
  • Clinical Trials
  • Clinical Trials

    Expand filters

    Filters

    Specialties

    • Cancer 2

    Showing 1 - 2 out of 2 results

    • Circulate
    • Clear All

    Cancer

    CIRCULATE

    Colorectal Cancer

    This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer

    Contact Research Team: [email protected]
    Site principal investigator: Marc Roth, MD
    Learn more about this study: NCT05174169

    Cancer

    EXActDNA-003

    Breast Cancer

    Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated With Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease

    Contact Research Team: [email protected]
    Site principal investigator: Whitney Hensing, MD
    Learn more about this study: NCT06401421
    • About
    • Careers
    • Community
    • Education
    • Employees
    • Medical Professionals
    • News
    Contact Us We're here to help

    Saint Luke's is committed to improving your experience. If you have questions, please call Saint Luke's Concierge at 816-932-5100, Monday–Friday, 7 a.m.–5 p.m. In case of emergency please call 911.

    More contact options
    © 2026 BJC Health. All Rights Reserved. 4901 Forest Park Ave. St. Louis, MO 63108
    • Patient Privacy
    • Price Transparency
    • Privacy Policy
    • Terms of Use